There were 556 press releases posted in the last 24 hours and 467,393 in the last 365 days.

UPDATE -- Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 9, 2016

Financial results conference call will include Investor and Analyst webcast presentation

GAITHERSBURG, Md., Nov. 02, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it will host an Investor and Analyst update as part of its third quarter financial results conference call and webcast after the close of U.S. financial markets on Wednesday, November 9, 2016.

Management will host a conference call to discuss the quarterly financial results and provide an update on corporate activities. Please be sure to join the webcast in order to access the slide presentation.

Conference call details are as follows:

Date: Wednesday, November 9, 2016
Time: 4:30 p.m. U.S. Eastern Time (ET)
Dial-in number: (877) 212-6076 (Domestic) or (707) 287-9331 (International)
Passcode:  10126707
Webcast:, “Investors”/ “Events”

Conference call replay:

Dates: Starting at 8:30 p.m. ET, November 9, 2016 until November 16, 2016
Dial-in number: (855) 859-2056 (Domestic) or (404) 537-3406 (International)
Passcode: 10126707
Webcast:, “Investors”/ “Events”

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. Its recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines.


Novavax, Inc.

Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer

Andrea N. Flynn, Ph.D.
Associate Director, Investor Relations

Primary Logo